SCHEMBL8202376

SCHEMBL8202376

Fc1cccc(-c2cccc(C3=NCCN3)c2)c1

nearest known ligand 0.93

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 15/20 0.93
MAOB P27338 1/20 0.58
ACHE P22303 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8201492 0.92 NISCH (0.84) NISCHMAOB
SCHEMBL8198758 0.89 NISCH (0.76) NISCHMAOBACHE
SCHEMBL9189709 0.88 NISCH (0.85) NISCHMAOBACHE
SCHEMBL24495491 0.84 NISCH (1.00) NISCHMAOBACHE
SCHEMBL8204316 0.83 NISCH (0.74) NISCHMAOB
SCHEMBL8202191 0.80 NISCH (0.73) NISCHMAOBACHE
SCHEMBL26119016 0.80 NISCH (0.73) NISCHMAOBACHE
SCHEMBL24495492 0.80 NISCH (0.93) NISCHMAOBACHE
Hydrochloric Acid SCHEMBL8194819 0.80 NISCH (0.70) NISCH
SCHEMBL24495603 0.79 NISCH (0.76) NISCHMAOBACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed